Navigating the Pre-IND Meeting: Strategic FDA Engagement for Biotech Success
October 9, 2025
For biotech startups and emerging sponsors, the Pre-Investigational New Drug (Pre-IND) meeting is a pivotal opportunity to align with the FDA before launching clinical trials.